<html>
<head>PUBMED IDs for ST6GALNAC2</head>
<body bgcolor='#C5F0F2'><h1>ST6GALNAC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17480010/'>Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy.</a> May 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19170967/'>Activity of alpha2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy.</a> February 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19357720/'>Interaction between variants of two glycosyltransferase genes in IgA nephropathy.</a> September 10  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20199106/'>Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.</a> August 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24520024/'>An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.</a> November 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27004849/'>Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer.</a> February 1  2016<br></body></html>
